The novel coronavirus disease 2019 (COVID-19) clinically manifests as respiratory and gastrointestinal presentations, most commonly vomiting, diarrhea, and abdominal pain. Although the impaired liver function is prevalent in COVID-19, it is poorly understood. We report the first case of hepatitis B virus (HBV) reactivation caused by COVID-19 in a young adult with altered mental status and severe transaminitis. The patient was asymptomatic, hypothermic, his skin was jaundiced with the icteric sclera, with very high levels of aspartate aminotransferase (AST; 4,933 U/L), alanine aminotransferase (ALT; 4,758 U/L), and total bilirubin (183.9 mmol/L) levels. It is warranted that patients with abnormal liver functions tend to have an increased risk of COVID-19. Thus, increased attention should be paid to the care of patients with abnormal liver functions, and testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is warranted in the COVID era.
【저자키워드】 viral infection, Novel coronavirus, COVID 19, hepatology, Liver function, UAE, adult gastroenterology, Hepatitis virus, viral hepatitis b, acute on chronic liver disease, 【초록키워드】 COVID-19, coronavirus, novel coronavirus disease, abdominal pain, diarrhea, RNA, HBV, COVID, Asymptomatic, Patient, Aspartate aminotransferase, Care, liver, Hepatitis B virus, Altered mental status, alanine aminotransferase, acute respiratory syndrome, total bilirubin, increased risk, transaminitis, functions, vomiting, impaired liver function, prevalent, caused, clinically, icteric, 【제목키워드】 COVID-19, novel, induced, United Arab Emirate,